Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llad069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Manrup K Hunjan und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Foundation Trust, Solihull, UK. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Simplex, Epidermolysis Bullosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: DEBRA.
Abstract (Originalsprache)
Our study demonstrates that severity scores do not correlate well with the impact that localized epidermolysis bullosa simplex (EBS) has on quality of life. There is a paucity of literature exploring correlations between disease severity and patient-reported outcome measures in EB. Both the Birmingham EB Severity (BEBS) score and EB Disease Activity and Severity Index (EBDASI) consist of weighted factors including body surface area, scalp, mucous membrane, nail and systemic involvement, as well as complications of longstanding disease such as cutaneous squamous cell carcinoma, which is more commonly seen in recessive dystrophic EB. Current scoring systems fail to account for the palmoplantar blistering and keratoderma which is the most significant source of morbidity in the EBS cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Foundation Trust, Solihull, UK.
- College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
- Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
ORCID-Profile: Manrup K Hunjan, Dario Leonardo Balacco, Adrian Heagerty
Förderung
- DEBRA
Zitieren
APA
Hunjan, M. K., Bardhan, A., Zuzarte, L., Balacco, D. L., Harper, N., & Heagerty, A. (2023). Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad069
Vancouver
Hunjan MK, Bardhan A, Zuzarte L, Balacco DL, Harper N, Heagerty A. Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad069
BibTeX
@article{Hunjan2023,
author = {Hunjan, Manrup K and Bardhan, Ajoy and Zuzarte, Louise and Balacco, Dario Leonardo and Harper, Natasha and Heagerty, Adrian},
title = {Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llad069}
}
EUVIMED